Insulet (NSDQ:PODD) shares ticked up today on second-quarter results that topped the consensus forecast.
The Acton, Mass.-based wearable insulin delivery system developer posted profits of $14.4 million, or 22¢ per share, on sales of $226.3 million for the three months ended June 30, 2020, for a bottom-line gain of nearly ten times as much as last year’s second-quarter profits on sales growth of 27.8%.
Get the full story at our sister site, Drug Delivery Business News.
